Expanding Treatment Opportunities: Reviewing the Current State of Injectable Antiretrovirals for Treatment of HIV

Abstract Antiretroviral therapy has evolved significantly over the last 20–30 years, from requiring multiple tablets multiple times per day to single-tablet regimens and most recently, in 2021, long-acting injectable antiretrovirals. These long-acting antiretrovirals have expanded the treatment opti...

Full description

Bibliographic Details
Published in:	Infectious Diseases and Therapy
Main Authors:	Amanda Binkley, Matty Zimmerman, Christina Maguire
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2024-10-01
Subjects:	Long-acting antiretrovirals HIV Antiretroviral therapy
Online Access:	https://doi.org/10.1007/s40121-024-01062-6

Similar Items

Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance
by: Charlotte Charpentier, et al.
Published: (2023-02-01)

Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in Kenya
by: Anne Kaggiah, et al.
Published: (2024-04-01)

Perceived benefits and barriers to the use of long-acting injectable antiretroviral treatment among adolescents and young people living with HIV in Western Kenya: qualitative findings from the KuwaFree! LiveFree! Study
by: Shukri A. Hassan, et al.
Published: (2025-03-01)

Anticipated facilitators and barriers for long-acting injectable antiretrovirals as HIV treatment and prevention in Vietnam: a qualitative study among healthcare workers
by: My T. Dang, et al.
Published: (2024-12-01)

Preparing for pharmacy-based delivery of long-acting injectable antiretrovirals: a pre-implementation study
by: Jennifer Cocohoba, et al.
Published: (2025-06-01)

Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case series
by: Christin Kilcrease, et al.
Published: (2022-11-01)

Receipt of long-acting injectable antiretroviral therapy among people with HIV in Southern US states: an assessment using electronic health records and claims data
by: Yiyang Liu, et al.
Published: (2025-02-01)

Knowledge attitudes and practices towards long-acting antiretroviral therapy in HIV/AIDS patients
by: Meixin Ren, et al.
Published: (2026-03-01)

Harnessing Pharmacokinetic Modeling to Develop a Long-Acting Subcutaneous HIV Treatment Platform for Young Children
by: Daniel Oliveira, et al.
Published: (2026-04-01)

Assessment of satisfaction with antiretroviral drugs and the need for long-acting injectable medicines among people living with HIV in Japan and its associated factors: a prospective multicenter cross-sectional observational study
by: Masashi Ishihara, et al.
Published: (2023-08-01)

Effectiveness and Persistence of Long‐Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort
by: Jara Llenas‐García, et al.
Published: (2026-04-01)

One size doesn’t fit all: Tailoring adult antiretroviral treatment
by: Nathan Geffen, et al.
Published: (2014-09-01)

What's new for antiretroviral treatment in women with HIV
by: Nisha Andany, et al.
Published: (2016-04-01)

PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION
by: V. A. Chibilyaev, et al.
Published: (2015-03-01)

“Injectable ARVs will give me peace” women’s acceptability of injectable antiretroviral therapy in prevention of HIV vertical transmission in Uganda
by: Deborah Ekusai -Sebatta, et al.
Published: (2025-07-01)

Editorial: New frontiers in HIV antiretroviral treatment: from the management of metabolic complications and chronic inflammation to new long-acting regimens
by: Salvatore Martini, et al.
Published: (2024-04-01)

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
by: Kimberly A. Koester, et al.
Published: (2023-10-01)

Long-acting antiretroviral therapy effectiveness and patient satisfaction using patient questionnaires: data from a real-world setting
by: Keiji Konishi, et al.
Published: (2024-09-01)

Determinants of adherence to antiretroviral drugs among people living with HIV/AIDS in the Ife-Ijesa zone of Osun state, Nigeria
by: Muhammed O. Afolabi, et al.
Published: (2009-04-01)

Brief communication: efficacy and safety of the dolutegravir/lamivudine dual therapy in antiretroviral treatment-experienced Chinese people living with HIV
by: Zhenyan Wang, et al.
Published: (2024-11-01)

A study of barriers to adherence of antiretroviral treatment in prisoners living with HIV in Tehran, Iran
by: Seyedahmad Seyedalinaghi, et al.
Published: (2020-06-01)

CEST MRI detects antiretroviral drug toxicities in the developing mouse brain
by: Micah Summerlin, et al.
Published: (2025-10-01)

A case of successful treatment with antiretroviral therapy for HIV in a patient with marked liver dysfunction
by: Hirofumi Fukuda, et al.
Published: (2022-11-01)

Impact of Combined Antiretroviral Treatment (cART) on Latent Cytomegalovirus Infection
by: Aura Temereanca, et al.
Published: (2025-01-01)

Polymer Delivery Systems for Long-Acting Antiretroviral Drugs
by: Mohammad Ullah Nayan, et al.
Published: (2024-01-01)

Trends Analysis of HIV Infection and Antiretroviral Treatment Outcome in Amhara Regional from 2015 to 2021, Northeast Ethiopia
by: Addisu T, et al.
Published: (2023-07-01)

Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system
by: Afiba Manza-A Agovi, et al.
Published: (2024-08-01)

Metabolic syndrome among people living with HIV on antiretroviral therapy in Mwanza, Tanzania
by: Evangelista Malindisa, et al.
Published: (2023-04-01)

Weight Gain in HIV Adults Receiving Antiretroviral Treatment: Current Knowledge and Future Perspectives
by: Konstantinos Markakis, et al.
Published: (2024-10-01)

Patient-reported tolerability and acceptability of cabotegravir + rilpivirine long-acting injections for the treatment of HIV-1 infection: 96-week results from the randomized LATTE-2 study
by: Miranda Murray, et al.
Published: (2019-09-01)

Persistence to single-tablet regimen versus less-drug regimen in treatment experienced HIV-infected patients on antiretroviral therapy
by: Rocio Jiménez-Galán, et al.
Published: (2016-07-01)

Non-adherence to antiretroviral treatment and associated factors among people living with HIV in Iran: a retrospective cohort study
by: Sima Afrashteh, et al.
Published: (2023-04-01)

Safety, Tolerability, and Metabolic Effects of Long-Acting Cabotegravir and Rilpivirine in HIV Care: A Comprehensive Review
by: Martina Bottanelli, et al.
Published: (2025-08-01)

Benchmarking long-acting injectable antiretroviral therapy against real-world oral antiretroviral therapy in southern China: a matching-adjusted indirect comparison of global trial data
by: Hongyu Chen, et al.
Published: (2026-07-01)

Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa
by: Leigh F. Johnson, et al.
Published: (2017-07-01)

Oral manifestations in HIV-positive individuals under highly active antiretroviral therapy: a systematic review and meta-analysis of prevalence data
by: Thais Suzigan Dagnoni, et al.
Published: (2026-03-01)

Assessment of efficiency of treatment of patients with acute HIV infection with use in the scheme of antiretroviral therapy elsulfavirin
by: Ya. S. Ulyanova, et al.
Published: (2021-07-01)

Nanotechnology and the Treatment of HIV Infection
by: Raveen Parboosing, et al.
Published: (2012-04-01)

Antiretroviral stewardship in a tertiary academic hospital: The need for a clinical pharmacist
by: Elmien Bronkhorst, et al.
Published: (2023-08-01)

Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort
by: Adriana Cervo, et al.
Published: (2023-09-01)